|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Sorrento Therapeutics (NASDAQ: SRNE) through any online brokerage.
The latest price target for Sorrento Therapeutics (NASDAQ: SRNE) was reported by Alliance Global Partners on 2021-01-21. The analyst firm set a price target for 35.00 expecting SRNE to rise to within 12 months (a possible 404.32% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Sorrento Therapeutics (NASDAQ: SRNE) is $6.94 last updated Mon Apr 12 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Sorrento Therapeutics.
There is no upcoming split for Sorrento Therapeutics.